Warsaw, Poland

Bartosz Foroncewicz

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 10.9

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Bartosz Foroncewicz**

Introduction

Bartosz Foroncewicz is a prominent inventor based in Warsaw, Poland, recognized for his innovative work in the field of medical diagnostics. He holds a significant patent that addresses a crucial aspect of nephrology, specifically focusing on IgA nephropathy.

Latest Patents

Foroncewicz's patent is titled "Methods for diagnosis, differentiation and monitoring using urine proteins as markers in IgA nephropathy." This invention introduces a method for diagnosing IgA nephropathy by utilizing a combination of specific protein markers found in urine samples from subjects. These markers include alpha-1B-glycoprotein (A1BG) or its truncated fragment with a molecular weight between 13-60 kDa, orosomucoid 1 (ORMI), and Ig lambda-2 chain C regions (IGLC2). This advancement holds the potential to improve the accuracy and effectiveness of diagnosing this kidney disorder.

Career Highlights

Throughout his career, Bartosz Foroncewicz has made significant contributions to the field of biochemistry and medical research. He has been associated with esteemed institutions, including the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and the Medical University of Warsaw. His work has focused on developing methods that enhance diagnostic processes in nephrology.

Collaborations

In his professional journey, Foroncewicz has collaborated with notable colleagues, such as Krzysztof Mucha and Leszek Paczek. These partnerships have contributed to the advancement of research in medical diagnostics, showcasing the importance of teamwork in innovation.

Conclusion

Bartosz Foroncewicz stands out as an influential inventor in the realm of medical diagnostics, particularly in the diagnosis of IgA nephropathy. His patented method utilizing urine protein markers reflects the vital role of innovation in improving healthcare outcomes. As he continues to work at the forefront of biochemistry and medical research, his contributions are anticipated to lead to further advancements in medical diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…